Answer
Guselkumab (Tremfya) is contraindicated in serious hypersensitivity to guselkumab or any excipient listed in section 6.1, and in clinically important active infections, such as active tuberculosis.
Sources for this answer
- Tremfya 100 mg OnePress solution for injection in pre-filled penJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 16Document updated
Sources checked